doctor head
 
  pharmacy and drugs  
search Search
 
       About us       News      A-Z Drugs      Stores      Top Drugs      Contact  
  doctor doctor hand
 
  doctor legs  
 
 
 
 

  Diseases

  Newsletter
Subscribe to our newsletter:
Name:
E-mail:
    Search results
Search results for: allergy

1 - 5 of 34 <<previous | next>>

Drugs results:

Elimite

Elimite

Elimite is the brand name for the medication permethrin a topical cream. Nix Cream Rinse and Acticin are other brand names for this same medication. This drug is a pediculicide and a scabicide, which means it treats lice. A pediculicide is a chemical a more...

Cetirizine pills

Cetirizine

Cetirizine is in a class of drug known as an antihistamine also called anti-pruritic. Pruritus is a medical term which means itchiness. Cetirizine blocks the actions of the naturally occurring chemical substance histamine in the body. Histamine is rele more...

Paxil CR

Paxil CR

Paxil CR is the brand name for the medication paroxetine. Other brand name packagings of parozetine are Paxil and Pexeva. This medication is an antidepressant of the group referred to as selective serotonin reuptake inhibitors (SSRIs). Paxil CR impact more...

Cefuroxime tablets

Cefuroxime

Cefuroxime is an antibiotic in a class of drugs called cephalosporin. Cefuroxime fights bacteria in the body. It is used to treat many different types of bacterial infections such as bronchitis, sinusitis, tonsillitis, ear infections, skin infections, g more...

Wellbutrin SR pills

Wellbutrin SR

Wellbutrin SR is the brand name for the generic drug bupropion. Other brand name packagings for this drug are Zyban SR, Wellbutrin SR XL, and Wellbutrin SR SR. This medication is an antidepressant, used to treat anxiety, seasonal affective disorder and more...

Diseases results:

Bacterial infection
Hives
Obsessive compulsive disorder
Attention Deficit Disorder
Skin diseases
Allergies
Asthma
Hay fever

Articles results:

UCB Obtains European Antitrust Clearance For Take-over Of Schwarz Pharma
As announced on November 10, 2006, the U.S. Federal Trade Commission (FTC) has allowed the waiting period to expire without expressing any concerns.Therefore, the take-over of SCHWARZ PHARMA by UCB can be pursued both from a European and U.S. antitrust perspective.Roch Doliveux, CEO of UCB said, "These two clearances represent major steps forward in our take-over process of SCHWARZ PHARMA.


Optimal Antigen Presentation For Sensitive Immunoassays
Dynal Bead Based Separations (part of the Invitrogen Group), has announced the introduction of a new immunoassay bead for in vitro diagnostic (IVD) applications - Dynabeads┬« MyOne™ Immunoassay (Carboxyl). This new bead type has been carefully developed to provide highly precise immobilization of small antigens such as peptides, steroids and hormones to the surface of the beads.


Schering-Plough To Pay $435M To Settle Allegations Of Improper Marketing
Schering-Plough on Wednesday was sentenced to pay $435 million as part of a settlement with the Department of Justice over accusations that the company improperly marketed prescription drugs for "off-label" use and lied to the government about drug prices, the Washington Post reports (Washington Post, 1/18).


Return On Investment For Pediatric Exclusivity Program Varies Widely For Pharmaceutical Companies
The economic return for a program designed to encourage drug manufacturers to conduct more pediatric clinical trials by granting extensions of patent protection or marketing exclusivity generates lucrative returns for blockbuster products and produces more modest returns on investment for many others, according to a study in the February 7 issue of JAMA.In 1997, Congress authorized the U.S.


Novel Treatment For ADHD - Shire And New River Pharmaceuticals Announce FDA Approval Of The First And Only Stimulant Prodrug VYVANSE
Shire plc (LSE: SHP, NASDAQ: SHPGY, TSX: SHQ) and its collaborative partner New River Pharmaceuticals Inc. (NASDAQ: NRPH) announced today that the U.S. Food and Drug Administration (FDA) has granted marketing approval for VYVANSE (lisdexamfetamine dimesylate, formerly known as NRP104), for the treatment of Attention Deficit Hyperactivity Disorder (ADHD). On February 20, 2007 Shire and New River announced an agreement whereby Shire will acquire New River for approximately $2.




1 - 5 of 34 <<previous | next>>

© 2006-2010 pharmacy-and-drugs.com. All rights reserved.